Aidence is now part of DeepHealth

Aidence was acquired in 2022 by RadNet, Inc., a leading provider of diagnostic imaging in the United States, then integrated into DeepHealth, a wholly owned subsidiary of RadNet. With a mission to empower breakthroughs in care through imaging, DeepHealth builds on and enhances the capabilities of the companies it has integrated and rebranded. As a global leader in AI-powered health informatics, DeepHealth aims to push the boundaries of what’s possible in healthcare by leveraging advanced AI to enable operational efficiency, clinical confidence, and better delivery of care, while elevating the experience for care teams through human-centered, intuitive technology.

Founded in 2015, Aidence was a radiology AI company focused on clinical solutions for pulmonary nodule management in routine practice and lung cancer screening. The company developed and deployed AI clinical applications to empower radiologists and other physicians in interpreting medical images. Their first commercialized product, Veye Lung Nodules (now DeepHealth Lung) was an AI-based solution for lung nodule detection classification, quantification, and growth assessment. This solution has been CE marked in Europe.